We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App





PET/CT Scans Showing Unusual Patterns Could Indicate Omicron, Warn Imaging Experts

By HospiMedica International staff writers
Posted on 17 Jan 2022
Print article
Image: PET/CT Scans Showing Unusual Patterns Could Indicate Omicron, Warn Imaging Experts (Photo courtesy of SNMMI)
Image: PET/CT Scans Showing Unusual Patterns Could Indicate Omicron, Warn Imaging Experts (Photo courtesy of SNMMI)

Scientists have recently observed an unusual imaging pattern on FDG PET/CT or FDG PET/MR that may be due to COVID-19 infection.

This new array of findings by the COVID-19 Task Force at the Society of Nuclear Medicine and Molecular Imaging (SNMMI; Reston, VA, USA) is primarily centered in the upper aerodigestive tract and cervical lymph nodes, unlike the FDG PET/CT pattern seen with infections from previous strains of COVID-19, with principal involvement of the lungs. Specifically, the scientists observed prominent, symmetric FDG uptake throughout the nasopharynx, oropharynx and tonsils with or without associated FDG-avid cervical lymphadenopathy, particularly in the suprahyoid neck. Based on what is known about the Omicron variant, the scientists believe that this pattern, whenever correlated with COVID-19 infection, is a result of the presently dominant Omicron strain.

The Task Force has recommended that this pattern should be taken into consideration at the time of FDG PET/CT interpretations and the possibility of infection with Omicron variant of COVID-19 should be entertained in the differential diagnosis. Since this pattern can by no means be diagnostic of COVID-19 infection, the Task Force has recommended checking the patient records to see if there is a recent positive COVID-19 test. It has also suggested determining if the patient is at higher risk of COVID-19 infection based on current symptoms or due to recent exposure or travel. If so, a recommendation can be made to test for COVID-19 in the appropriate setting, according to the Task Force.

Additionally, the Task Force has suggested comparing with prior FDG PET/CT examinations and the patient’s history to determine if this represents chronic inflammatory/reactive process or stable malignancy such as lymphoma. Various differential diagnostic possibilities should be considered if this pattern is new or if there is interval progression including, but not limited to, infection with COVID-19, other viruses such as Epstein-Barr virus, malignancy and bacterial infections. This pattern may also be seen in children and younger adults but should be interpreted cautiously in view of normal increased activity that can be physiologic. Correlation with history and symptoms and comparison to prior examinations is recommended by the Task Force.

Related Links:
SNMMI

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Endoscopic Suturing System
OverStitch
New
Radiation Shielding
Oversize Thyroid Shield

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.